Insulin switch & Algorithms Rotorua GP CME June Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB
|
|
|
- Octavia Lawrence
- 8 years ago
- Views:
Transcription
1 Insulin switch & Algorithms Rotorua GP CME June 2011 Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB
2 Goal of workshop Insulin switching make the necessary move Ensure participants are confident with Recognising when insulin should be changed Understanding switching algorithms Use of Rapid acting Insulins
3 Jackie
4 Medical history 56-year-old teacher History of hypertension Diagnosed with diabetes 5 years ago Commenced premixed insulin 8 months ago Has come to see you as she is concerned about her weight: put on 9 kg since she started on insulin She is also having morning hypos
5 Medications Premixed insulin (30:70): 25 units twice daily Increased from 12 units twice daily over past 8 months No oral hypoglycaemics Inhibace: 5 mg daily Hydrochlorothiazide: 12.5 mg daily Simvastatin: 40 mg daily
6 Examination/investigations BP: 145/90 mmhg Was well controlled with ACE inhibitor until this visit BMI 30 kg/m 2 (Height 158 cm; weight 75 kg) Total cholesterol: 6.1 mmol/l Triglycerides increased from 1.5 to 3.2 mmol/l since last measured 2 months ago HbA1c: 7.9% egfr: 55 ml/min No other obvious causes of weight gain (e.g. hypothyroidism)
7 How does insulin contribute to weight gain?
8
9 Weight gain in T2D Lifestyle, nutrition Prandial insulin Improved glycaemic control Weight gain Premixed insulin Short-acting component Oral hypoglycaemic agents Incorrect or over-use of insulin 1. Phillips P. KISS Part 2. Medicine Today 2007; 8(4):
10 Which of these oral hypoglycaemic agents is associated with the least weight gain? A. Pioglitazone B. Glipizide C. DPP-4 inhibitors D. Metformin E. All about the same in terms of weight gain
11 * How would you adjust Jackie s medication to address her weight? A. Introduce metformin * to the twice daily premixed insulin schedule B. Switch from twice daily premixed to basal/bolus C. Switch from twice daily premixed to twice-daily long-acting basal insulin D. Switch from twice daily premixed to once-daily long-acting basal insulin and re-introduce metformin * E. None of the above
12 Switching insulins Switch from premixed insulin (30:70) BD to oncedaily long-acting basal insulin (at bedtime) and introduce metformin Calculate the dose of long-acting basal insulin to be given at bedtime 1. Phillips P. KISS Part 4. Medicine Today 2007; 8(6): Consider a further 10% dose decrease if severe hypoglycaemia has occurred in the past 1
13 Premixed BD to long-acting basal 25 units premixed insulin twice daily (50U) (30: 70) 30% of 50 units is rapid-acting insulin 15 units 70% of 50 units is basal insulin 35 units Reduce dose by 20% 0.8 x 35 units = 28 units/day longacting basal
14 Converting from premixed to longacting basal insulin Premixed once daily Use 100% of total basal dose once daily* Premixed twice daily Use 70-80% of total basal dose once daily* *Fix the fasting BG then review the need for prandial insulin Davies M et al. Diabetes Care 2005; 28:
15 Managing other likely contributors to Jackie s weight gain Monitor her eating, activity and insulin schedules closely and amend them to compensate for decreased glycosuria Encourage her to eat less and walk more Arrange a dietician review for Jackie
16 What would you consider now to manage her triglyceride levels? 1. Optimise glycaemic control 2. Increase physical activity 3. Consider omega-3 fatty acid supplementation 4. Increase her statin dose 5. All of the above?
17 Hypertriglyceridaemia Priority is to optimise glycaemic control 1 Dietary advice will help lipid profile and weight Lower total fat intake 1 Increase intake of omega 3 fats 1 with diet or supplementation (5 mg/day) Increase dietary fibre 1 Ask about alcohol intake Modify/add pharmacological agents only if required 1 Could increase dose of statin Add fenofibrate or gemfibrozil if hypertriglyceridaemia plus hypercholesterolaemia persists (care with myopathy) 1. NHMRC T2D guidelines, lipid control, 2004.
18 How does alcohol affect glycaemic control? 1. Can cause delayed hypoglycaemia 2. Can cause hyperglycaemia 3. Causes immediate weight loss 4. Can increase weight gain 5. 1, 2 and 4 above?
19 Effects of alcohol In addition to its potential to affect glycaemic control, alcohol: Is associated with increased HDL-cholesterol and triglycerides 1 Can cause significant weight gain as high in calories 2 and may promote fat deposition 3,4 1. NHMRC T2D guidelines, lipid control, Healthy eating and diabetes. Alcohol and diabetes. The Queen Elizabeth Hospital Diabetes Centre, Australian guidelines. To reduce health risks from drinking alcohol. NHMRC, GrogWatch newsletter, 34 th issue, October 2007.Community Alcohol Action Network, an initiative of the Australian Drug Foundation.
20 12 weeks later... Jackie returns for a follow-up appointment: Glycaemic control remains reasonable (A1c 7.4%) Lost 2 kg during the first 6 weeks but weight has plateaued since then
21 What could be behind Jackie s weight loss plateauing?
22 On questioning Jackie... You find that she: Hasn t been exercising Intends to but never finds the time Is worried about hypoglycaemia with insulin Has been eating more carbohydrate in the day Was told by a friend on insulin to have regular carbohydrate snacks as well as her three meals Feels better and may have been eating more because of this
23 What would you suggest now?
24 Next steps for Jackie Suggest Jackie: 1 Adjusts hypoglycaemic medication to suit lifestyle not vice versa Increase physical activity As her GP, be content with an A1c of 7.4% at least until weight is controlled 1 Jackie needs support to establish confidence in her new insulin regimen and re-learn how to adjust her dietary carbohydrate intake and insulin dosing 1. Phillips P. KISS Part 2. Medicine Today 2007; 8(4):
25 Remember... Increased physical activity and weight loss will also improve Jackie s hypertension: 1 Intervention Blood pressure reduction (mmhg) Weight loss* 15/8 Aerobic exercise 4/3 *9 kg in 6 months. This, in turn, will help improve the microvascular 2 and cardiovascular outcomes 1 of her diabetes 1. NHMRC T2D guidelines, BP control, UKPDS 33. Lancet 1998; 352:
26 What are your key learnings in managing potential weight gain at insulin commencement?
27 Practice points 1. Rapid-acting insulin rarely needed at insulin commencement common reason for: Increased appetite Weight gain Hypoglycaemia 2. Don t stop metformin at insulin commencement Increases insulin sensitivity
28 Practice points 3. Encourage eat less, walk more 4. Don t adjust patient s lifestyle to match the insulin Adjust the hypoglycaemic treatment to match patient s lifestyle (and preferably work on optimising that) 5. Educate on alcohol
29 Practice points 6. Metabolic control in type 2 diabetes always addresses: Blood glucose Blood pressure Blood lipids Absolute cardiovascular risk assessment tool from NZ Heart Foundation, NZGG, Predict etc
30 Steve
31 Medical history 63-year-old engineer, lives with wife Diagnosed with diabetes 8 years ago Commenced on NPH insulin nocte 6 months ago Currently on 24 units nocte in addition to Metformin and Gliclazide. Glycaemia improved from 8.9% to 7.6% since starting him on insulin Eats mainly breakfast and dinner due to his work. Steve presents to you for review.
32 Steve s BG readings Fasting Post-breakfast Pre-dinner Post-dinner Wednesday Thursday Friday 5.9 Saturday Sunday Monday 6.2 Tuesday Wednesday
33
34 Suitable insulin regimens Twice daily Premix insulins 1/3 rd of current NPH insulin dose as mane (8) and current NPH insulin dose as evening (24)Premix insulin (HumalogMix 25 or Penmix 30) NPH insulin plus prandial insulin Rapid acting analogue 4-6 units with meals and aim for post-prandial BGs around 6-8 Continue current OHAs If hypos, consider reducing/stopping Sulphonyl urea (Gliclazide).
35
36 Insulin Switch- NPH to Long acting analogues (Glargine or Detemir) From once daily NPH 1 unit of NPH= 1 unit of Long acting analogue From twice daily NPH 80 % of total daily (NPH) dose= Units of Long acting analogue
37 Insulin Switch- NPH to Twice daily premix insulins eg;penmix 30/70, HumalogMix 25/75 If already on twice daily NPH dose, initiate same dose of Premix insulin dose twice daily If on once a day NPH insulin, you may consider splitting the dose twice daily. Either 2/3 rd in the morning and 1/3 rd in the evening with meals eg; Patient is on 60 units of NPH insulin, therefore you can split the dose as 40 units of premix insulin mane and 20 units of premix insulin in the evening.
38 Insulin Switch- Twice daily PreMix insulins to Basal bolus regimen Calculate Basal Insulin dose (eg; Glargine/Detemir) 1. Determine Total daily dose of NPH eg: Patient on Penmix 30 insulin 50 units twice daily ( NPH 35 units and Regular insulin 15 units twice daily) Lantus/Levemir dose would be =80% of 70 Units of NPH=56 units Calculate bolus insulin dose (eg; Apidra, Novorapid or Humalog) Above patient will need = total daily dose of regular insulin 3, 30/3= 10 units
39 Insulin Switch- Basal insulin to Twice daily PreMix insulins eg; Penmix 30 or HumalogMix 25 Calculate the total daily basal insulin dose 2 options; give 2/3rd in the morning with breakfast and 1/3rd with dinner meal or give ½ with breakfast and ½ with dinner meal eg: Patient takes 46 units of NPH at night and 34units of NPH at breakfast Therefore, either 40 units twice daily or 54 units mane and 26units evening of Premix insulin
40 Rapid acting insulins Novorapid/Humalog/Apidra All are essentially similar efficacy Similar action profiles Needs to be taken with meals
41
42 Start Protaphane/Humulin N 10 units (0.2U/kg bedtime) or long acting basal insulin analogue 10 units at bedtime or mane Increase dose 2 units every 3-4 days until mean fasting BG < 6mmol/L Make sure there is no rebound hyperglycaemia in the mane No HbA1C >7 % after 3/12 Yes If hypo, decrease dose by 4 units or 10% of the dose if >60 units Continue regimen and monitor A1C 3/12ly Fasting O.K. then check pre meals and add second injection, 6-8 units mane, adjust every 3-4 days until pre meals <6 mmol/l A1C > 7%, check post meal blood glucoses and add rapid acting analogues 4-6 units with meals or change to Penmix/Humalogmix/Novomix twice daily, 0.2 units/kg mane and 0.1u/kg evening Monitor A1C every 3/12
43 Thank you.
Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2
Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick
Initiating & titrating insulin & switching in General Practice Workshop 1
Initiating & titrating insulin & switching in General Practice Workshop 1 Workshop goal To make participants comfortable in the timely initiation and titration of insulin Progression of Type 2 Diabetes
Insulin use in Type 2 Diabetes. Dr Rick Cutfield. Why? When? How?
Insulin use in Type 2 Diabetes Dr Rick Cutfield Why? When? How? 1 Conflict of Interest I have been on advisory boards or had speaker fees from the following pharmaceutical companies: - Eli Lilly - Novo
TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES
TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES Non-insulin regimes Basal insulin only (usually with oral agents) Number of injections 1 Regimen complexity Low Basal insulin +1 meal-time rapidacting insulin
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย
Diabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
Workshop A Tara Kadis
Workshop A Tara Kadis Considerations/barriers in decision making about insulin verses GLP-1 use in people with type 2 diabetes Which Insulin regimes should we consider? Diabetes is a progressive multi-system
Algorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
User guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE
The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step
Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB
Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Declarations I have received travel funding and speaker fees
Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
When and how to start insulin: strategies for success in type 2 diabetes
1 When and how to start insulin: strategies for success in type diabetes Treatment of type diabetes in 199: with each step treatment gets more complex Bruce H.R. Wolffenbuttel, MD PhD Professor of Endocrinology
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:
Guideline for members of the diabetes team and dietetic department for advising on insulin dose adjustment and teaching the skills of insulin dose adjustment to adults with type 1 or type 2 diabetes mellitus
Glycaemic Control in Adults with Type 1 Diabetes
Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes
Intensifying Insulin Therapy
Intensifying Insulin Therapy Rick Hess, PharmD, CDE, BC-ADM Associate Professor Gatton College of Pharmacy, Department of Pharmacy Practice East Tennessee State University Johnson City, Tennessee Learning
Resident s Guide to Inpatient Diabetes
Resident s Guide to Inpatient Diabetes 1. All patients with diabetes of ANY TYPE, regardless of reason for admission, must have a Hemoglobin A1C documented in the medical record within 24 hours of admission
Everyday Practice: Diabetes Mellitus
THE NATIONAL MEDICAL JOURNAL OF INDIA VOL. 20, NO. 5, 2007 245 Everyday Practice: Diabetes Mellitus Insulin therapy for patients with type 2 diabetes mellitus NISHA R. S., E. BHATIA INTRODUCTION India
INSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
Information for Patients
Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist
Clinical Guideline Diabetes management during surgery (adults)
Clinical Guideline Diabetes management during surgery (adults) Standard 8 of the National Service Framework for Diabetes states that all children, young people and adults with diabetes admitted to hospital,
Insulin onset, peak and duration of action
Insulin onset, peak and duration of action Insulin was first discovered in the early 190 s. Before then, diabetes could not be treated. Insulin was then taken from cow and pig pancreases, but nearly all
Insulin/Diabetes Calculations
Insulin/Diabetes Calculations Dr. Aipoalani St Lukes Endocrinology Goals Describe various calculations for insulin dosing Understand importance of the total daily dose (TDD) of insulin Be able to calculate
Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes
Diabetes Sans Frontières Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes 1. Introduction This guideline has been developed in order to support practices to undertake insulin therapeutic
ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST
ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST Vahid Mahabadi, MD Research grants from Sanofi and Amylin Pharmaceutical Companies Mayer B. Davidson, MD Advisory Board Sanofi Pharmaceutical Company Chief
Insulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
The Early Use of Insulin and Oral Anti diabetic Drugs
The Early Use of Insulin and Oral Anti diabetic Drugs NPS Outreach Pharmacists for Remote Aboriginal Health Services Strategy A remote perspective Dr Hugh Heggie National Medicine Policy To provide timely
Presented By: Dr. Nadira Husein
Presented By: Dr. Nadira Husein I have no conflict of interest Disclosures I have received honoraria/educational grants from the following: Novo Nordisk, Eli Lilly, sanofi-aventis, Novartis, Astra Zeneca,
Leicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
Intensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
SHORT CLINICAL GUIDELINE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SHORT CLINICAL GUIDELINE SCOPE 1 Guideline title Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 1.1 Short title Type 2
An introduction to carbohydrate counting
An introduction to carbohydrate counting Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
Treatment of patients with type 2 diabetes: from text book therapy to personalized medicine
1 Treatment of patients with type 2 diabetes: from text book therapy to personalized medicine BruceH H.R. Wolffenbuttel, MDPhD Professor of Endocrinology & Metabolism University Medical Center Groningen
Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
Cochrane Quality and Productivity topics
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration
of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast
I have diabetes. In case of emergency, please call: Healthcare Provider s Name. Name. Telephone. Address. Hospital. City. Pharmacy.
Self-Care Diary Name Address City Healthcare Provider s Name Hospital State ZIP I have diabetes. In case of emergency, please call: Name Pharmacy Diabetes Educator s Name Address 1 Small Steps to Managing
Insulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
Type 2 diabetes mellitus
Type 2 diabetes mellitus CLINICAL PRACTICE Management Guidelines for initiating insulin therapy BACKGROUND Insulin is often indicated for patients with suboptimally controlled type 2 diabetes mellitus,
Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes
PL Detail-Document #300128 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER January 2014 Initiation and Adjustment of Insulin Regimens for Type
Diabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types
Insulin Therapy In Type 2 DM Michael Fischer, M.D., M.S. Sources of support NaRCAD is supported by a grant from the Agency for Healthcare Research and Quality My current research projects are funded by
Advanced Carbohydrate Counting
Advanced Carbohydrate Counting Living Well with Your Health Conditions What is Carbohydrate Counting? Carbohydrate counting focuses on the amount of carbohydrate (carbs) in your diet. Carbohydrate is the
Diabetes in Pregnancy: Management in Labour
1. Purpose The standard management of labour applies to women with diabetes, and includes the following special considerations: Timing of birth. Refer to guideline: Diabetes Mellitus - Management of Pre-existing
This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.
Information for the public Published: 2 December 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care
Insulin therapy in various type 1 diabetes patients workshop
Insulin therapy in various type 1 diabetes patients workshop Bruce H.R. Wolffenbuttel, MD PhD Dept of Endocrinology, UMC Groningen website: www.umcg.net & www.gmed.nl Twitter: @bhrw Case no. 1 Male of
DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1)
DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1) KEY PRINCIPLES Many patients with Type 2 diabetes will require insulin therapy. In the UKPDS over 50% of patients by 6 years required additional
Shanmugasundar G., Anil Bhansali, Rama Walia, Pinaki Dutta & Vimal Upreti
Indian J Med Res 135, January 2012, pp 78-83 Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus A
Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust
Insulin or GLP1 How to make this choice in Practice Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust Workshop Over View Considerations/barriers to treatments in type 2
81 Central Street, Houghton Estate, 2198 PO Box 2900, Saxonwold, 2132 www.cdediabetes.co.za
81 Central Street, Houghton Estate, 2198 PO Box 2900, Saxonwold, 2132 www.cdediabetes.co.za Clinical Guidelines 2015 The Use of Antibody Testing in the Management of Diabetes Mellitus When should the Antibody
INSULIN REGIMENS in type 2 diabetes
A review of INSULIN and INSULIN REGIMENS in type 2 diabetes a Joshi P, PhD, FRCP,FRS Med, FICA Joshi S, MBChB, MSc(Pharm) Med(UL) Diabetes Care Centre, Louis Pasteur Medical Centre, Pretoria a Emeritus
Insulin Dependent Diabetes Trust
Insulin Dependent Diabetes Trust Type 2 and You January 2010 Registered Company Number 3148360 Registered Charity No 1058284 We are sending this issue of Type 2 and You out early as it has some useful
Insulin Pump Therapy
CHILDREN S SERVICES Insulin Pump Therapy These guidelines are not intended for starting a patient on an insulin pump. They are intended to give staff not part of the diabetic team information regarding
Insulin initiation in type 2 diabetes: Experience and insights
Insulin initiation in type 2 diabetes: Experience and insights Joan Everett A diagnosis of type 2 diabetes can be devastating for the individual and their family. Furthermore, many people with diabetes
Func%onal insulin therapy: rela%onship to carbohydrate intake
Func%onal insulin therapy: rela%onship to carbohydrate intake Prof. Andrej Janež MD, PhD University Medical Centre Ljubljana, Slovenia Conflict of interests Merck Sharp&Dohme, Novo Nordisk, NovarEs, Boehringer
End of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy In addition to using the blood sugar logs to adjust your insulin doses every week, you should also use your continuous glucose
Blood Sugar Log. Breakfast (daily) Before Lunch Before Dinner Bedtime
Blood Sugar Log Date Before Breakfast (daily) Before Lunch Before Dinner Bedtime DIABETES MANAGEMENT (HEMOGLOBIN A1c) Your Hemoglobin A1c is the blood test that tells your doctor how well you are managing
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
Diabetes Subcommittee of PTAC meeting. held 18 June 2008. (minutes for web publishing)
Diabetes Subcommittee of PTAC meeting held 18 June 2008 (minutes for web publishing) Diabetes Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics
Diabetes Monitoring Diary
Diabetes Monitoring Diary For those Counting Diabetes Service My targets: Before breakfast Before other meals Before bed... mmol/l... mmol/l... mmol/l Correcting high blood glucose levels: Information
Surgery and Procedures in Patients with Diabetes
Surgery and Procedures in Patients with Diabetes University Hospitals of Leicester NHS Trust DEFINITIONS Minor Surgery and Procedures: expected to be awake, eating and drinking by the next meal, total
Insulin pens workshop Making the complex simple
Agenda: Insulin doses Needles Insulin Pen Devices Insulin storage Key information (Patient &HCP) Injection sites Hypoglycaemia Home blood glucose testing Sick day advice Traveling Sharps Insulin pens workshop
Pharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
Many patients with type 2 diabetes will ultimately need
SUPPLEMENT TO JAPI april 2011 VOL. 59 17 Insulin Initiation and Intensification: Insights from New Studies Ajay Kumar 1, Sanjay Kalra 2 Abstract Tight glycemic control is central to reducing the risk of
Initiate Atorvastatin 20mg daily
Type 2 Diabetes Patient Objectives Stopping Smoking BMI > 25 kg m² Control BP to
Changing to Basal Bolus Insulin Regimen
Changing to Basal Bolus Insulin Regimen What is a basal bolus insulin regimen? Basal insulin (Lantus) is injected once per day and ensures there is insulin in the body at all times. Bolus insulin (NovoRapid/Humalog)
Starting Insulin Sooner Than Later
Starting Insulin Sooner Than Later Rotorua GP Insulin Seminar 13 June 2014 Kingsley Nirmalaraj MBBS, FRACP, FACE Consultant Endocrinologist and Physician Tauranga Hospital/ Bay Endocrinology Ltd Declaration
Cancer treatment and diabetes
Cancer treatment and diabetes Dr Daniel Morganstein Consultant Endocrinologist, 1 2 Diabetes and cancer Cancer and its treatment also poses challenges to managing diabetes Surgery Altered appetite Cachexia
Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.
Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels Take a moment Confer with your neighbour And try to solve the following word
Emma Jenkins BSc, RD, CEDT Diabetes Specialist Dietitian Royal Bournemouth Hospital Dorset, UK. Pens & calculators at the ready?!...
Emma Jenkins BSc, RD, CEDT Diabetes Specialist Dietitian Royal Bournemouth Hospital Dorset, UK Pens & calculators at the ready?!... Robert, age 42. Type 1 diabetes for 26yrs. HbA1c 76mmols/mol 2 recent
How to adjust your insulin if taken two or three times daily. To change the insulin dose, you will need to know:
What to do if your results are too high or too low The target range for your blood glucose results is from to 8 mmol/l - aim to have four out of every five blood glucose results in this range. If three
Updates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes
dates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO Managing Complicated Diabetes Diabetes is increasingly common Managing diabetes and working as part of a multidisciplinary team is essential
Diabetes in Primary Care course MCQ Answers 2016
Diabetes in Primary Care course MCQ Answers 2016 Diagnosis of Diabetes HbA1C should not be used as a diagnostic tool in the following situations: (answer each TRUE or FALSE) 1. Gestational Diabetes TRUE
Designer Insulins. History case 1. Follow up - case 1. Follow up - case 1. History - case 2. 24 hr glucose profile - case 1
History case 1 33 yr old male bank manager Designer Insulins Dr A Qureshi MB ChB (Edin), MD (Lon), CCT (Lon), FRCP (Lon) Consultant in Endocrinology, Diabetes and General Internal Medicine w w w. e n d
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
Insulin Treatment. J A O Hare. www.3bv.org. Bones, Brains & Blood Vessels
Insulin Treatment J A O Hare www.3bv.org Bones, Brains & Blood Vessels Indications for Insulin Treatment Diabetic Ketoacidosis Diabetics with unstable acute illness ICU Gestational Diabetes: diet failure
A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes
A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes 1. Summary... 1 2. Background... 2 3. Purpose 2 4. Responsibilities. 2 5. Blood Glucose Monitoring. 2 6. Resident Groups that
Britni Hebert, MD PGY-1
Britni Hebert, MD PGY-1 Importance of Diabetes treatment Types of treatment Comparison of treatment/article Review Summary Example cases 1 out of 13 Americans have diabetes Complications include blindness,
The first injection of insulin was given on
EFFECTIVE USE OF INSULIN THERAPY IN TYPE 2 DIABETES * Bernard Zinman, MDCM ABSTRACT Type 2 diabetes is a progressive disease; an individual s ability to secrete insulin in increasing amounts to overcome
Insulin pen start checklist
Insulin pen start checklist Topic Instruction Date & Initials 1. Cognitive Assessment 2. Insulin Delivery loading appropriate mixing priming shot dialing up dose delivery of insulin 3. Insulin type/action
Primary Care Type 2 Diabetes Update
Primary Care Type 2 Diabetes Update May 16, 2014 Presented by: Barb Risnes APRN, BC-ADM, CDE Objectives: Discuss strategies to address common type 2 diabetes patient management challenges Review new pharmacological
Insulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk
Insulin therapy in type 2 diabetes When and how? Cecilia C Low Wang, MD Univ Colorado AMC SOM Department of Medicine Division of Endocrinology, Metabolism, and Diabetes Disclosures None relevant to today
Insulin myths and facts
london medicines evaluation network Insulin myths and facts Statement 1 Insulin is the last resort for patients with Type 2 diabetes After initial metformin and sulfonylurea therapy, NICE and SIGN suggest
SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS
SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS PURPOSE To establish a process that will enable Certified Diabetes Educators (CDE) and/or staff with Board Certification in Advanced Diabetes Management
Most patients with T2DM will eventually require insulin therapy. ADA Glycemic Control Targets. What are some of the obstacles?
ADA Glycemic Control Targets A1C < 7% Preprandial plasma glucose 70-130 mg/dl Postprandial plasma glucose (PPG)
Using human insulin in line with the NICE guideline on type 2 diabetes:
Using human insulin in line with the NICE guideline on type 2 diabetes: Inside: Insulin initiation in type 2 diabetes: What should we be doing? Matthew Oldfield Human insulin in clinical practice: A series
IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL
464 IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL PRACTICE STEPHAN A SCHREIBER AND ANIKA RUßMAN ABSTRACT
NCT00272090. sanofi-aventis HOE901_3507. insulin glargine
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:
Diabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th 2013. Presenter: Derek Sanders, D.Ph.
Diabetes and the Elimination of Sliding Scale Insulin Date: April 30 th 2013 Presenter: Derek Sanders, D.Ph. Background Information Epidemiology and Risk Factors Diabetes Its Definition and Its Impact
Prior Authorization Guideline
Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval
Intensifying Insulin In Type 2 Diabetes
Intensifying Insulin In Type 2 Diabetes Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine and Health Sciences Assistant
Calculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
Type 2 Diabetes. Management and Medication. HELPLINE: 01604 622837 www.iddtinternational.org
I N D E P E N D E N T D I A B E T E S T R U S T Type 2 Diabetes Management and Medication A charity supporting and listening to people who live with diabetes HELPLINE: 01604 622837 www.iddtinternational.org
INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE
INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE We welcome feedback on this policy and the way it operates. We are interested to know of any possible or actual adverse impact that this policy/procedure
Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults
Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Stock # 45-11647 Revised 10/28/10 Glycemic Goals 1,2 Individualize goal based on patient risk factors A1c 6%